For instance, HOTAIRM1 inhibitors have been developed to block the upregulation of PD-1 in T-cells, thereby reversing T-cell exhaustion and improving immune function in preclinical models of sepsis [44]. This evidence concerns the gene PDCD1 and Sepsis.